IL1B and arthritic joint disease: As shown in Fig. 5H, GMs significantly reduced the serum concentrations of TNF-α and IL-1β, which are known to increase with the development of arthritis and correlate strongly with disease severity37, showing modestly better anti-inflammation effects than aTNF-α.